Intervention for incipient patients at low risk of disease progression (DrugBank: -)
1 diseaseID | Disease name (Link within this page) | Number of trials |
---|---|---|
66 | IgA nephropathy | 1 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT04438603 (ClinicalTrials.gov) | October 1, 2020 | 17/6/2020 | The Applicaiton of Immune Repertoire in the Diagnosis and Disease Monitoring of IgA Nephropathy | The Applicaiton of Immune Repertoire in the Diagnosis and Disease Monitoring of IgA Nephropathy | IgA Nephropathy | Drug: Intervention for incipient patients at low risk of disease progression;Drug: Intervention for patients at high risk of disease progression | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | RenJi Hospital;Shanghai Zhongshan Hospital;Longhua Hospital Shanghai University of Traditional Chinese Medicine | Recruiting | 18 Years | 80 Years | All | 180 | China |